Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis

Ann Rheum Dis. 2021 Jun;80(6):e87. doi: 10.1136/annrheumdis-2020-218258. Epub 2020 Jun 30.

¹ Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
² Department of Radiology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
³ Department of Internal Medicine 1-Gastroenterology, Pneumology and Endocrinology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
⁴ Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Bayern, Germany joerg.distler@uk-erlangen.de.

No abstract available

Keywords: glucocorticoids; hydroxychloroquine; sarcoidosis.

Publication types